FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program-Reference-Cited by-同舟云学术

FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program

Published:2021-08 Issue:8 Volume:29 Page:2583-2600
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zhang Ming,Hoyle Rosalie G.,Ma Zhikun,Sun Bo,Cai Weixin,Cai Hongshi,Xie Nan,Zhang Yadong,Hou Jinsong,Liu Xiqiang,Chen Demeng,Kellogg Glen E.,Harada Hisashi,Sun Yue,Wang Cheng,Li Jiong^ORCID

Funder

National Natural Science Foundation of China

NIDCR

Virginia Commonwealth University

VCU Massey Cancer Center

Elsa U Pardee Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference68 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

2. Master transcription factors and mediator establish super-enhancers at key cell identity genes;Whyte;Cell,2013

3. Super-enhancers in the control of cell identity and disease;Hnisz;Cell,2013

4. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer;Chipumuro;Cell,2014

5. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription;Jang;Mol. Cell,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel prognostic signature derived from super-enhancer-associated gene by machine learning in head and neck squamous cell carcinoma;Oral Oncology;2024-12

2. Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells;Bioorganic Chemistry;2024-10

3. Super‐Enhancer Driven LIF/LIFR‐STAT3‐SOX2 Regulatory Feedback Loop Promotes Cancer Stemness in Head and Neck Squamous Cell Carcinoma;Advanced Science;2024-08-29

4. Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma;2024-08-27

5. Head and neck cancer: pathogenesis and targeted therapy;MedComm;2024-08-21